Manuel Taboada to Anticholesteremic Agents
This is a "connection" page, showing publications Manuel Taboada has written about Anticholesteremic Agents.
Connection Strength
0.054
-
Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy. Atherosclerosis. 2003 Jun; 168(2):289-95.
Score: 0.054
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.